To validate the early xenograft tumor onset of AnxA6 deficient BT-A6A cells, we demonstrate that injection of fewer cells delayed tumor onset in a dose dependent manner followed by rapid growth of the ensuing xenograft tumors (Figure 3D). This evidence concerns the gene ANXA6 and neoplasm.